We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Kyle Bass' Coalition Gets PTAB Review Of Anacor Patents

Law360, New York (February 24, 2016, 7:56 PM EST) -- The Patent Trial and Appeal Board will review two patents for the Anacor Pharmaceuticals Inc. toenail fungus treatment Kerydin, ruling Tuesday that an organization started by hedge fund manager Kyle Bass had shown the patents are likely invalid.

The board found the Coalition for Affordable Drugs had presented sufficient evidence to justify instituting inter partes review of the two patents. The group had argued both were invalid because they were obvious.

“We conclude that petitioner has established a reasonable likelihood of prevailing on its assertions that...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.